Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11191)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2022 (publication date) through Feb 26, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Tornai D, Ven PL, Lakatos PL, Papp M. Serological biomarkers for management of primary sclerosing cholangitis. World J Gastroenterol 2022; 28(21): 2291-2301 [PMID: 35800183 DOI: 10.3748/wjg.v28.i21.2291] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Tornai D, Ven PL, Lakatos PL, Papp M. Serological biomarkers for management of primary sclerosing cholangitis. World J Gastroenterol 2022; 28(21): 2291-2301 [PMID: 35800183 DOI: 10.3748/wjg.v28.i21.2291] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i21/2291.htm |
| Number | Citing Articles |
| 1 |
Ugo Ala, Sharmila Fagoonee. RNA-binding protein transcripts as potential biomarkers for detecting Primary Sclerosing Cholangitis and for predicting its progression to Cholangiocarcinoma. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1388294
|
| 2 |
E. A. Aleksandrova, A. A. Novikov, P. I. Kulakova, E. N. Koltsova, M. A. Borisova, G. V. Lukina. Inflammatory bowel disease-associated antibodies in ankylosing spondylitis: relationship with clinical and laboratory markers of inflammation. Medical alphabet 2026; 1(34): 28 doi: 10.33667/2078-5631-2025-34-28-33
|
| 3 |
Kathleen Möller, Barbara Braden, Emma L. Culver, Christian Jenssen, Ehsan Safai Zadeh, Amjad Alhyari, Christian Görg, André Ignee, Michael Hocke, Yi Dong, Siyu Sun, Siegbert Faiss, Christoph F. Dietrich. Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging. Endoscopic Ultrasound 2023; 12(2): 181 doi: 10.4103/EUS-D-22-00208
|
| 4 |
Atsushi Oyama, Akinobu Takaki, Takuya Adachi, Nozomu Wada, Yasuto Takeuchi, Hideki Onishi, Hidenori Shiraha, Hiroyuki Okada, Motoyuki Otsuka. Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan. Hepatology International 2023; 17(5): 1215 doi: 10.1007/s12072-023-10557-2
|
| 5 |
Payam Hashemi, James L. Boyer, Jonathan H. Langdon. The Utility of Elastography in Discriminating Stages of Liver Fibrosis and Risk Stratification in Patients With Primary Sclerosing Cholangitis: A Systematic Review. Journal of Magnetic Resonance Imaging 2026; doi: 10.1002/jmri.70266
|
| 6 |
Wei-Lu Wang, Haoran Lian, Yingyu Liang, Yongqin Ye, Paul Kwong Hang Tam, Yan Chen. Molecular Mechanisms of Fibrosis in Cholestatic Liver Diseases and Regenerative Medicine-Based Therapies. Cells 2024; 13(23): 1997 doi: 10.3390/cells13231997
|
| 7 |
Savino Sciascia, Nicola Bizzaro, Pier Luigi Meroni, Bogdanos Dimitrios, Maria Orietta Borghi, Xavier Bossuyt, Claudia Grossi, Dávid Tornai, Maria Papp, Yehuda Shoenfeld, Daniele Ielo, Marvin J. Fritzler. Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value. Autoimmunity Reviews 2023; 22(7): 103356 doi: 10.1016/j.autrev.2023.103356
|
| 8 |
Ganimete Bajraktari, Tanja Elger, Muriel Huss, Johanna Loibl, Andreas Albert, Arne Kandulski, Martina Müller, Hauke Christian Tews, Christa Buechler. Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis. International Journal of Molecular Sciences 2024; 25(9): 4765 doi: 10.3390/ijms25094765
|
| 9 |
Mariko Maxwell, David N. Assis. Update on Biomarkers in Primary Sclerosing Cholangitis. Current Hepatology Reports 2026; 25(1) doi: 10.1007/s11901-025-00720-8
|
| 10 |
Peter Laszlo Ven, David Tornai, Bence Toth, Zsuzsanna Vitalis, Istvan Tornai, Tamas Tornai, Gabriella Par, Maria Papp. Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC Cohort. Diagnostics 2025; 15(17): 2166 doi: 10.3390/diagnostics15172166
|
| 11 |
Tanja Fererberger, Christa Buechler, Arne Kandulski, Tanja Elger, Johanna Loibl, Stephan Schmid, Stefanie Sommersberger, Stefan Gunawan, Sebastian Zundler, Muriel Huss, Dominik Bettenworth, Sally Kempa, Simon Weidlich, Bandik Föh, Xinyu Huang, Marcin Grzegorzek, Stefanie Derer-Petersen, Ulrich L. Günther, Jens U. Marquardt, Claudia Kunst, Karsten Gülow, Martina Müller, Christian Sina, Franziska Schmelter, Hauke C. Tews. Distinct metabolomic and lipidomic profiles in serum samples of patients with primary sclerosing cholangitis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1334865
|
| 12 |
Martti Färkkilä, Fredrik Åberg, Henrik Alfthan, Kalle Jokelainen, Lauri Puustinen, Hannu Kautiainen, Andrea Tenca. Surrogate markers of bile duct disease progression in primary sclerosing cholangitis – A prospective study with repeated ERCP examinations. JHEP Reports 2024; 6(10): 101161 doi: 10.1016/j.jhepr.2024.101161
|
| 13 |
Hauke Christian Tews, Tanja Elger, Stefan Gunawan, Tanja Fererberger, Stefanie Sommersberger, Johanna Loibl, Muriel Huss, Gerhard Liebisch, Martina Müller, Arne Kandulski, Christa Buechler. Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01929-6
|
| 14 |
Sofia Svensson Di Giorgio, Chiara Maria Scandavini, Antonio Molinaro, Urban Arnelo, Roberto Valente. Primary Sclerosing Cholangitis: Diagnosis, Management, and Clinical Challenges. Journal of Clinical Medicine 2026; 15(3): 1149 doi: 10.3390/jcm15031149
|
| 15 |
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
|